Composition of Other Balance Sheet Items (Tables)

3 Months Ended

Mar. 31, 2024

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of inventories

Inventories, Net

	March 31, 2024		December 31, 2023
	(unaudited)
Raw materials	$	18,803	$	16,274
Work in process	23,246		31,212
Finished goods	33,030		29,922
Total	$	75,079	$	77,408

Schedule of property and equipment

Property and Equipment, Net

	March 31, 2024		December 31, 2023
	(unaudited)
Lab equipment and furniture	$	13,120	$	13,069
Leasehold improvements	14,023		14,023
Software	883		883
Computer equipment	960		960
	28,986		28,935
Less accumulated depreciation and amortization	(16,017)		(15,405)
Property and equipment, net	$	12,969	$	13,530

Schedule of accrued expenses and other current liabilities

Accounts Payable and Accrued Liabilities

	March 31, 2024		December 31, 2023
	(unaudited)
Accounts payable	$	14,397	$	1,964
Accrued compensation, benefits, & related accruals	16,444		20,722
Accrued sales & marketing	13,263		11,666
Accrued manufacturing expenses	9,118		11,652
Accrued R&D expenses	9,092		10,530
Operating lease liabilities, current portion (2)	9,133		8,331
Accrued royalties (1)	6,963		7,918
Other accrued expenses	7,992		6,786
Total	$	86,402	$	79,569

_______________________________

(1) Refer to Note 15, Commitments and Contingencies.

(2) Refer to Note 12, Leases.

Schedule of accrued product returns and rebates

Accrued Product Returns and Rebates

	March 31, 2024		December 31, 2023
	(unaudited)
Accrued product rebates	$	107,681	$	96,984
Accrued product returns	59,545		57,290
Total	$	167,226	$	154,274